1. Ji, Jing, Shen, Jing, Xu, Yuxin, Liu, Wei, Liu, Bin. 2022. FBXO2 targets glycosylated SUN2 for ubiquitination and degradation to promote ovarian cancer development. In Cell death & disease, 13, 442. doi:10.1038/s41419-022-04892-9. https://pubmed.ncbi.nlm.nih.gov/35525855/
2. Tecalco-Cruz, Angeles C, Macías-Silva, Marina, Sosa-Garrocho, Marcela, Figueroa-Rivera, Leslie, López-Camarillo, César. 2024. Molecular interplay between the upregulated levels of Sad1 and UNC84 Domain Containing 2 (SUN2) and gene expression in medulloblastoma cells. In Molecular biology reports, 51, 1164. doi:10.1007/s11033-024-10078-7. https://pubmed.ncbi.nlm.nih.gov/39560853/
3. Donahue, Daniel A, Amraoui, Sonia, di Nunzio, Francesca, Casartelli, Nicoletta, Schwartz, Olivier. 2016. SUN2 Overexpression Deforms Nuclear Shape and Inhibits HIV. In Journal of virology, 90, 4199-4214. doi:10.1128/JVI.03202-15. https://pubmed.ncbi.nlm.nih.gov/26865710/
4. Donahue, Daniel A, Porrot, Françoise, Couespel, Norbert, Schwartz, Olivier. 2017. SUN2 Silencing Impairs CD4 T Cell Proliferation and Alters Sensitivity to HIV-1 Infection Independently of Cyclophilin A. In Journal of virology, 91, . doi:10.1128/JVI.02303-16. https://pubmed.ncbi.nlm.nih.gov/28077629/